We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Letters Seen as Attempt to Limit Compounding
FDA Letters Seen as Attempt to Limit Compounding
September 6, 2006
The FDA moved to stop several pharmacies from manufacturing compounded inhalation drugs in the agency’s latest attempt to curb a practice that it believes to be unsafe.